Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Suvanjaa Sivalingam"'
Autor:
Suvanjaa Sivalingam, Emil List Larsen, Daniel H. van Raalte, Marcel H. A. Muskiet, Mark M. Smits, Lennart Tonneijck, Jaap A. Joles, Bernt Johan von Scholten, Emilie Hein Zobel, Frederik Persson, Trine Henriksen, Lars Jorge Diaz, Tine W. Hansen, Henrik Enghusen Poulsen, Peter Rossing
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Glucagon-like peptide 1 receptor agonists have shown cardioprotective effects which have been suggested to be mediated through inhibition of oxidative stress. We investigated the effect of treatment with a glucagon-like peptide 1 receptor ag
Externí odkaz:
https://doaj.org/article/3bcc699d77684b339336dcb21eb97295
Publikováno v:
Endocrine Connections, Vol 7, Iss 10, Pp 1090-1095 (2018)
Background: Season of birth, an exogenous indicator of early life environment, has been linked with a higher risk of adverse health outcomes such as autoimmune thyroiditis, multiple sclerosis and schizophrenia later in life. Whether the development a
Externí odkaz:
https://doaj.org/article/5c469f9437a24fd9930feaf0c041718b
Autor:
null Suvanjaa Sivalingam, null Emilie H. Zobel, null Christian S. Hansen, null Rasmus S. Ripa, null Bernt J. Scholten, null Viktor R. Curovic, null Andreas Kjaer, null Jacob K. Jensen, null Tine W. Hansen, null Peter Rossing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f0444c9a90ebe1192db4fdf5f9359c
https://doi.org/10.1111/dom.14717/v3/response1
https://doi.org/10.1111/dom.14717/v3/response1
Autor:
Suvanjaa Sivalingam, Emilie Hein Zobel, Christian S. Hansen, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Andreas Kjaer, Jacob K. Jensen, Tine W. Hansen, Peter Rossing
Publikováno v:
Sivalingam, S, Hein Zobel, E, Hansen, C S, Ripa, R S, von Scholten, B J, Rotbain Curovic, V, Kjaer, A, Jensen, J K, Hansen, T W & Rossing, P 2022, ' The effect of liraglutide on cardiac autonomic function in type 2 diabetes : A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial ', Diabetes, Obesity and Metabolism, vol. 24, no. 8, pp. 1638-1642 . https://doi.org/10.1111/dom.14717
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be039184676f0a0a182a07f6e898bf9d
https://curis.ku.dk/portal/da/publications/the-effect-of-liraglutide-on-cardiac-autonomic-function-in-type-2-diabetes(57e75839-98c2-4cf1-95a3-d9e832ee6194).html
https://curis.ku.dk/portal/da/publications/the-effect-of-liraglutide-on-cardiac-autonomic-function-in-type-2-diabetes(57e75839-98c2-4cf1-95a3-d9e832ee6194).html
Autor:
Mark M. Smits, Emil List Larsen, Emilie H. Zobel, Daniël H. van Raalte, Bernt Johan von Scholten, Lennart Tonneijck, Suvanjaa Sivalingam, Tine W. Hansen, Marcel H. A. Muskiet, Jaap A. Joles, Frederik Persson, Lars Jorge Diaz, Henrik E. Poulsen, Trine Henriksen, Peter Rossing
Publikováno v:
Scientific Reports
Scientific Reports, 11(1):10624. Nature Publishing Group
Sivalingam, S, Larsen, E L, van Raalte, D H, Muskiet, M H A, Smits, M M, Tonneijck, L, Joles, J A, von Scholten, B J, Zobel, E H, Persson, F, Henriksen, T, Diaz, L J, Hansen, T W, Poulsen, H E & Rossing, P 2021, ' The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes ', Scientific Reports, vol. 11, no. 1, 10624 . https://doi.org/10.1038/s41598-021-90191-w
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports, 11(1):10624. Nature Publishing Group
Sivalingam, S, Larsen, E L, van Raalte, D H, Muskiet, M H A, Smits, M M, Tonneijck, L, Joles, J A, von Scholten, B J, Zobel, E H, Persson, F, Henriksen, T, Diaz, L J, Hansen, T W, Poulsen, H E & Rossing, P 2021, ' The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes ', Scientific Reports, vol. 11, no. 1, 10624 . https://doi.org/10.1038/s41598-021-90191-w
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Glucagon-like peptide 1 receptor agonists have shown cardioprotective effects which have been suggested to be mediated through inhibition of oxidative stress. We investigated the effect of treatment with a glucagon-like peptide 1 receptor agonist (li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3a754cc228dea7ca5adfeaed315e3ef
http://europepmc.org/articles/PMC8134438
http://europepmc.org/articles/PMC8134438